---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-043441"
form_type: "8-K"
ticker: "MIRA"
cik: "0001904286"
company_name: "MIRA PHARMACEUTICALS, INC."
filed_at: "2023-12-01T23:59:59+00:00"
generated_at: "2026-06-07T19:35:53.798836+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Mira Pharmaceuticals: Director Brian Daly resigns; Michael Jerman becomes Audit Committee Chair

## Summary
- Brian Daly resigned from the Board effective December 1, 2023; he had served as Audit Committee Chair and Compensation Committee member.
- Michael Jerman appointed Chairman of the Audit Committee on December 1, 2023; had been appointed to the committee on November 14, 2023.
- Daly's resignation was not due to any disagreement with the Company, management, or Board on operations, policies, or practices.

## SEC filing metadata
- accession: 0001493152-23-043441
- form_type: 8-K
- ticker: MIRA
- cik: 0001904286
- company_name: MIRA PHARMACEUTICALS, INC.
- filed_at: 2023-12-01T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1904286/000149315223043441/0001493152-23-043441-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1904286/000149315223043441/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-043441
- JSON: https://secwatch.observer/filing/0001493152-23-043441.json
- Plain text: https://secwatch.observer/filing/0001493152-23-043441.txt

## Key facts
- Executive change
  Brian Daly resigned as Director at MIRA PHARMACEUTICALS, INC..
  - Action: resigned
  - Role: Director
  source text: on December 1, 2023, Brian Daly resigned from the Board of Directors of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1904286/000149315223043441/0001493152-23-043441-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.